Cargando…

Harnessing the B Cell Response in Kidney Transplantation – Current State and Future Directions

Despite dramatic improvement in kidney transplantation outcomes over the last decades due to advent of modern immunosuppressive agents, long-term outcomes remain poor. Antibody-mediated rejection (ABMR), a B cell driven process, accounts for the majority of chronic graft failures. There are currentl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anwar, Imran J., DeLaura, Isabel F., Gao, Qimeng, Ladowski, Joseph, Jackson, Annette M., Kwun, Jean, Knechtle, Stuart J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223638/ https://www.ncbi.nlm.nih.gov/pubmed/35757745 http://dx.doi.org/10.3389/fimmu.2022.903068

Ejemplares similares

Complement-targeted therapies in kidney transplantation—insights from preclinical studies
por: Anwar, Imran J., et al.
Publicado: (2022)

Complement-targeting therapeutics for ischemia-reperfusion injury in transplantation and the potential for ex vivo delivery
por: Delaura, Isabel F., et al.
Publicado: (2022)

Desensitization and belatacept-based maintenance therapy in pregnancy-sensitized monkeys receiving a kidney transplant
por: Manook, Miriam, et al.
Publicado: (2023)

Editorial: Sensitization and Desensitization in Organ Transplantation
por: Anwar, Imran J., et al.
Publicado: (2021)

Commentary: Belatacept Does Not Inhibit Follicular T Cell-Dependent B-Cell Differentiation in Kidney Transplantation
por: Schroder, Paul M., et al.
Publicado: (2017)

Gene Therapy: Will the Promise of Optimizing Lung Allografts Become Reality?
por: Gao, Qimeng, et al.
Publicado: (2022)

Allo-Specific Humoral Responses: New Methods for Screening Donor-Specific Antibody and Characterization of HLA-Specific Memory B Cells
por: Song, Shengli, et al.
Publicado: (2021)

Harnessing Treg Homeostasis to Optimize Posttransplant Immunity: Current Concepts and Future Perspectives
por: Ikegawa, Shuntaro, et al.
Publicado: (2021)

Editorial: Future challenges and directions in determining allo-immunity in kidney transplantation
por: Lim, Wai H., et al.
Publicado: (2022)

Harnessing immunosurveillance: current developments and future directions in cancer immunotherapy
por: Drakes, Maureen L, et al.
Publicado: (2014)

Emerging New Approaches in Desensitization: Targeted Therapies for HLA Sensitization
por: Choi, Ashley Y., et al.
Publicado: (2021)

IL-15 Harnesses Pro-inflammatory Function of TEMRA CD8 in Kidney-Transplant Recipients
por: Tilly, Gaëlle, et al.
Publicado: (2017)

Optimal Immunosuppression Strategy in the Sensitized Kidney Transplant Recipient
por: Olaso, Danae, et al.
Publicado: (2021)

Tolerogenic therapies in transplantation
por: Page, Eugenia K., et al.
Publicado: (2012)

Simultaneous pancreas and kidney transplantation: current trends and future directions
por: Redfield, Robert R., et al.
Publicado: (2015)

IL-21 Biased Alemtuzumab Induced Chronic Antibody-Mediated Rejection Is Reversed by LFA-1 Costimulation Blockade
por: Kwun, Jean, et al.
Publicado: (2018)

Immunotherapy in Lung Cancer: Current Landscape and Future Directions
por: Mamdani, Hirva, et al.
Publicado: (2022)

Current Status and Future Directions of Bacteria-Based Immunotherapy
por: Tang, Quan, et al.
Publicado: (2022)

Harnessing T Cells to Control Infections After Allogeneic Hematopoietic Stem Cell Transplantation
por: Basso, Sabrina, et al.
Publicado: (2020)

Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions
por: Mao, Lili, et al.
Publicado: (2021)

Current landscape and future directions of bispecific antibodies in cancer immunotherapy
por: Wei, Jing, et al.
Publicado: (2022)

CCHFV vaccine development, current challenges, limitations, and future directions
por: Ahata, Büşra, et al.
Publicado: (2023)

Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A Review
por: Slepicka, Priscila Ferreira, et al.
Publicado: (2021)

Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation
por: Morath, Christian, et al.
Publicado: (2020)

Editorial: Pandemic influenza vaccine approaches: Current status and future directions
por: Schotsaert, Michael, et al.
Publicado: (2022)

Gut microbiota in perioperative neurocognitive disorders: current evidence and future directions
por: Sun, Yan, et al.
Publicado: (2023)

Cell-based and cell-free immunotherapies for glioblastoma: current status and future directions
por: Wang, Mingming, et al.
Publicado: (2023)

Bat behavioral immune responses in social contexts: current knowledge and future directions
por: Stockmaier, Sebastian
Publicado: (2023)

The interplay of inflammation and remodeling in the pathogenesis of chronic rhinosinusitis: current understanding and future directions
por: Gong, Xinru, et al.
Publicado: (2023)

Liver Transplantation for Hepatocellular Carcinoma after Downstaging or Bridging Therapy with Immune Checkpoint Inhibitors
por: Gao, Qimeng, et al.
Publicado: (2021)

Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation
por: Couzi, Lionel, et al.
Publicado: (2015)

Novel Non-Histocompatibility Antigen Mismatched Variants Improve the Ability to Predict Antibody-Mediated Rejection Risk in Kidney Transplant
por: Pineda, Silvia, et al.
Publicado: (2017)

Immunotherapy for hepatocellular carcinoma recurrence after liver transplantation, can we harness the power of immune checkpoint inhibitors?
por: Jiang, Jingyu, et al.
Publicado: (2023)

Insights into the role of neutrophils in neuropsychiatric systemic lupus erythematosus: Current understanding and future directions
por: Sim, Tao Ming, et al.
Publicado: (2022)

Harnessing Unconventional T Cells for Immunotherapy of Tuberculosis
por: La Manna, Marco P., et al.
Publicado: (2020)

Harnessing NK Cells for Cancer Treatment
por: Minetto, Paola, et al.
Publicado: (2019)

Corrigendum: Novel Non-Histocompatibility Antigen Mismatched Variants Improve the Ability to Predict Antibody-Mediated Rejection Risk in Kidney Transplant
por: Pineda, Silvia, et al.
Publicado: (2018)

Chronovaccination: Harnessing circadian rhythms to optimize immunisation strategies
por: Otasowie, Claire O., et al.
Publicado: (2022)

A cell-based multiplex immunoassay platform using fluorescent protein-barcoded reporter cell lines
por: Song, Shengli, et al.
Publicado: (2021)

New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future Directions
por: Saidu, Nathaniel Edward Bennett, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1tn8j7oi3cjo6ecgenijdk33re